Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case Study

JCO Oncol Pract. 2021 Jul;17(7):379-381. doi: 10.1200/OP.21.00073. Epub 2021 Apr 19.

Authors

Stephen M Schleicher^{1

2}, Basit Chaudhry³, Natalie R Dickson^{1

2}, Emeline Aviki⁴, Edward Arrowsmith^{1

2}, Ravi B Parikh^{5

6}, Andrew T Yue³, Nora Connor³, Lee Schwartzberg^{2

7}, Aaron J Lyss²

Affiliations

¹ Tennessee Oncology, Nashville, TN.
² OneOncology, Nashville, TN.
³ Tuple Health, Washington, DC.
⁴ Memorial Sloan Kettering Cancer Center, New York, NY.
⁵ Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
⁶ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
⁷ West Cancer Center, Memphis, TN.

PMID: 33872069
DOI: 10.1200/OP.21.00073

No abstract available

Publication types

Editorial

MeSH terms

Critical Pathways
Humans
Lung Neoplasms* / therapy
Precision Medicine*